At the Mater Hospital we conduct a wide range of research projects, particularly in the area of cancer. The Mater has extended its research endeavours and capabilities with the opening of the Mater Clinic, which includes two research areas, and establishment of The Poche Centre, which reinforces the St Vincents Health Australia commitment to research.

The Patricia Ritchie Centre for Cancer Care and Research

The Patricia Ritchie Centre for Cancer Care and Research houses a busy clinical chemotherapy service, research office and multidisciplinary teams in breast cancer, gynaecological cancer and head and neck cancer. These are closely linked to surgical, radiation oncology and diagnostic services within the hospital and many clinicians have academic appointments at the University of Sydney.

Accessing the best cancer treatment may involve participation in the clinical trial of promising new therapies. These trials offer patients access to revolutionary medications years before they are readily available.

The Patricia Ritchie Centre offers a range of clinical trials to patients with cancer. Working closely with national and international academic groups, the centre has been involved in practice changing cancer research over the past 10 years, most notably in relation to HER2 positive breast cancer treatment. The committed financial support of The Friends of the Mater assists key researcher salaries, making many of the centre’s endeavours possible.

Melanoma Institute Australia

The world’s largest melanoma treatment and research centre, The Poche Centre is home to Melanoma Institute Australia. Made possible through a generous donation of $40 million from philanthropist Mr Greg Poche AO, the purpose built centre is a world class, integrated cancer treatment centre. The Poche Centre expands existing Mater cancer services and its establishment enables the very best possible care for melanoma patients.

Dedicated to minimising the devastating impact of melanoma on the community, Melanoma Institute Australia is affiliated with St Vincents Health Australia as well as the University of Sydney.

Melanoma is the most common form of cancer in individuals aged between 15 and 39 in Australia and establishment of Melanoma Institute Australia, within the Poche Centre, signals a new era in Australia’s ability to progress research, education and treatment of melanoma. In association with the St Vincents Health Australia, Melanoma Institute Australia will minimise the devastating impact of melanoma on national and international communities.